Home › Funds › Bain Capital Life Sciences Investors, LLC › OLMA
Bain Capital Life Sciences Investors, LLC position in OLMA
OLEMA PHARMACEUTICALS INC · Health Care
Bain Capital Life Sciences Investors, LLC reported holding 7,085,249 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$61.2M, representing 4.21% of its reported portfolio and ranking #10 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed OLMA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Bain Capital Life Sciences Investors, LLC's OLMA position evolved
Bain Capital Life Sciences Investors, LLC first disclosed a stake in OLMA in Q4 2024 at 7,470,214 shares (US$43.6M). The position peaked in Q4 2025 at 8,508,641 shares, worth US$212.7M. Across 8 filings, Bain Capital Life Sciences Investors, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 7,085,249 shares valued at US$61.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 7.47M | $43.55M | New |
| Q1 2025 | 6.84M | $25.73M | Reduce |
| Q2 2025 | 6.84M | $29.16M | Hold |
| Q3 2025 | 6.84M | $67.00M | Hold |
| Q4 2025 | 8.51M | $212.72M | Add |
| Q1 2026 | 7.47M | $111.43M | Reduce |
| Q2 2026 | 7.09M | $88.64M | Reduce |
| Q3 2026 | 7.09M | $61.22M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OLMA and 13F data
OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$75.3M), BVF INC/IL (US$66.3M), Siren, L.L.C. (US$42.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OLMA
- Paradigm Biocapital Advisors LP 8.72M sh · $75.35M · Q3 2026
- BVF INC/IL 5.30M sh · $66.25M · Q2 2026
- Siren, L.L.C. 4.86M sh · $41.96M · Q3 2026
- Logos Global Management LP 3.21M sh · $27.72M · Q3 2026
- Cormorant Asset Management, LP 2.15M sh · $26.90M · Q2 2026
- Lightspeed Management Company, L.L.C. 1.36M sh · $11.71M · Q3 2026
- Defilade Capital Management, L.P. 924.76K sh · $11.57M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 1.20M sh · $10.37M · Q3 2026
More on Bain Capital Life Sciences Investors, LLC
FAQ
How long has Bain Capital Life Sciences Investors, LLC held OLMA?
Bain Capital Life Sciences Investors, LLC has disclosed OLMA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Bain Capital Life Sciences Investors, LLC's current position in OLMA?
As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 7.09M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $61.22M, representing 4.21% of its reported portfolio and ranking #10.
Has Bain Capital Life Sciences Investors, LLC been buying or selling OLMA?
In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in OLMA. The position peaked in Q4 2025 at 8.51M shares.
Which other funds hold OLMA?
Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, BVF INC/IL, Siren, L.L.C., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.